SCHEMBL5698471

SCHEMBL5698471

COc1c(Cl)ccc(NC([NH])=O)c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 3/20 0.47
HSD17B10 Q99714 1/20 0.47
TAS1R3 Q7RTX0 8/20 0.47
TAS1R1 Q7RTX1 8/20 0.47
TAS1R2 Q8TE23 6/20 0.47
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 1/20 0.40
RAF1 P04049 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7133200 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL3739876 0.72 BRD4 (0.53) ALDH1A1KDM4EKMT2ALMNAHPGD
SCHEMBL19927338 0.72 ALDH1A1 (0.47) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL2088329 0.69 RAF1 (0.53) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL2088326 0.69 RAF1 (0.53) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL2093882 0.69 RAF1 (0.53) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL8667615 0.68 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10TAS1R3TAS1R1
SCHEMBL7495952 0.68 RAF1 (0.52) ALDH1A1KDM4ETAS1R3TAS1R1TAS1R2
SCHEMBL2013991 0.68 KMT2A (0.62) ALDH1A1KDM4ETAS1R3TAS1R1TAS1R2
SCHEMBL6353680 0.68 KMT2A (0.71) ALDH1A1KDM4EHSD17B10L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed